Trump's Pharma Tariffs Spare Richest Drugmakers
Big companies like Novartis say new tariffs won't hit them. "A win for Pharma,†Wall Street analysts said.


Glideslope AI-powered market news
No market stories in the last 7 days. The latest coverage is below.

No scored stories in the last 7 days.
| Day | Mood | Stories |
|---|---|---|
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
Big companies like Novartis say new tariffs won't hit them. "A win for Pharma,†Wall Street analysts said.

The US and EU have released details of the new trade deal reducing tariffs between the two partners.

Trump told CNBC's "Squawk Box" that planned tariffs on pharmaceuticals imported into the U.S. could eventually reach up to 250%.

AstraZeneca said the "cornerstone" of the commitment would be a new weight management production facility for its oral GLP-1 drug.

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE